Modernizing USP Melatonin Monograph Assay and Impurities Methods for Increased Throughput and Reduced Solvent Waste

Significance of the Topic

Melatonin is a widely used neurohormone for managing sleep disorders. Recent reports of pediatric ingestion incidents and variable melatonin content in supplements emphasize the need for robust quality control. Standardized assays ensure label accuracy and consumer safety.

Objectives and Overview of the Study

This application note describes a modernized version of the USP Melatonin monograph assay and impurity methods, implemented on a Waters Arc HPLC system. The goal is to shorten analysis time, reduce solvent consumption, and maintain compliance with USP system suitability requirements.

Methodology and Instrumentation

The study adopted USP sample preparations with minor adjustments to mobile phase composition within USP 621 guidelines. Key parameters include:

• Column: XBridge BEH C18, 130 Å, 2.5 µm, 4.6 mm × 75 mm
• System: Waters Arc HPLC with 2998 Photodiode Array Detector
• Data system: Empower 3 CDS
• Mobile phase for assay: acetonitrile and phosphate buffer (22:78 v/v), isocratic, 5 min
• Mobile phases for impurities: gradient elution over 13 min
• Flow rate: 1.0 mL/min, column temperature 30 °C
• Detection: UV at 222 nm

Main Results and Discussion

• Assay run time reduced to 5 min with a single isocratic step
• Impurity profile obtained in 13 min using a gradient program
• System suitability metrics met USP criteria: relative retention times, resolution, and RSD (0.11%) for melatonin peak area
• Flow rate optimization balanced plate count and analysis speed; bypassing preheating tubing minimized band broadening

Benefits and Practical Applications

• Increased sample throughput enables faster decision making in quality control
• Reduced solvent use lowers operational costs and environmental impact
• Compatibility with existing USP standards ensures regulatory compliance
• Adaptable approach for routine analysis in pharmaceutical and supplement industries

Future Trends and Opportunities

• Integration of sub-2 µm and core–shell columns for further efficiency gains
• Application of advanced detectors and multiplexed workflows for high-throughput labs
• Exploration of greener solvent systems and sustainable consumables
• Extension of method modernization to other monographs and complex matrices

Conclusion

The modernized USP method on the Waters Arc HPLC system achieves rapid, reliable melatonin assay and impurity analysis. It meets all system suitability requirements while reducing run times and solvent waste, supporting efficient quality control in supplement and pharmaceutical manufacturing.

Reference

1. Auld F, Maschauer EL, Morrison I, Skene DJ, Riha RL. Evidence for the efficacy of melatonin in the treatment of primary adult sleep disorders. Sleep Med Rev. 2017;34:10–22.
2. Lelak K, Vohra V, Neuman MI, Toce MS, Sethuraman U. Pediatric melatonin ingestions—United States, 2012–2021. MMWR Morb Mortal Wkly Rep. 2022;71(22):725–729.
3. Erland LAE, Saxena PK. Melatonin natural health products and supplements: presence of serotonin and significant variability of melatonin content. J Clin Sleep Med. 2017;13(2):275–281.
4. Cohen PA, Avula B, Wang YH, Katragunta K, Khan I. Quantity of melatonin and CBD in melatonin gummies sold in the US. JAMA. 2023;329(16):1401–1402.
5. United States Pharmacopeia. Melatonin Monograph. 2023.
6. United States Pharmacopeia. Chapter 621: Chromatography. 2023.